Document Detail


4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity.
MedLine Citation:
PMID:  19733043     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of polyunsaturated fatty acids (PUFAs) obtained from the diet on colorectal cancer have been widely explored. However, controversial results have been obtained about the role played by the lipid peroxidation products of PUFAs, such as 4-hydroxy-nonenal (HNE), in the control of colon cancer growth. This aldehyde, indeed, showed both procarcinogenic and protective effects. In an attempt to verify the action of HNE, we studied the effects of a low dose of HNE (1 microM), similar to those "physiologically" found in normal cells and plasma, on telomerase activity, a key parameter of malignant transformation. Caco-2 cells were exposed to HNE and, paralleling cell growth inhibition, we observed the down-regulation of telomerase activity and hTERT expression. Similar effects have also been observed in HT-29 cells, in which HNE inhibited cell proliferation, telomerase activity and hTERT expression, suggesting that the inhibition of telomerase activity could be a general mechanism involved in the antiproliferative effect exerted by this aldehyde. Finally, we elucidated the mechanism of hTERT inhibition by HNE. A reduction of GSH content preceded the decrease of telomerase activity, but this only partially explained the telomerase activity inhibition. The major mechanism of HNE action seems to be the modulation of expression and activity of transcription factors belonging to the Myc/Mad/Max network. Since the presence of PUFAs in the diet exposes epithelial colon cells to HNE, this aldehyde could contribute to cell growth control through the inhibitory action on telomerase activity and hTERT expression, suggesting a protective effect on colon mucosa.
Authors:
Stefania Pizzimenti; Elisa Menegatti; Daniela Berardi; Cristina Toaldo; Piergiorgio Pettazzoni; Rosalba Minelli; Barbara Giglioni; Angelo Cerbone; Mario U Dianzani; Carlo Ferretti; Giuseppina Barrera
Related Documents :
20175753 - Immortalization of bovine mammary epithelial cells alone by human telomerase reverse tr...
7660243 - Aging and degeneration of the human intervertebral disc.
19625373 - Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-09-03
Journal Detail:
Title:  The Journal of nutritional biochemistry     Volume:  21     ISSN:  1873-4847     ISO Abbreviation:  J. Nutr. Biochem.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-23     Completed Date:  2010-11-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9010081     Medline TA:  J Nutr Biochem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  818-26     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
Affiliation:
Department of Medicine and Experimental Oncology, University of Turin, Torino, Italy. stefania.pizzimenti@unito.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aldehydes / pharmacology*
Apoptosis / drug effects
Caco-2 Cells
Cell Differentiation / drug effects
Cell Division / drug effects
Cell Proliferation / drug effects
Colorectal Neoplasms / genetics
Down-Regulation
Gene Expression / drug effects
Glutathione / metabolism
HT29 Cells
Humans
Lipid Peroxidation / drug effects
Telomerase / antagonists & inhibitors*,  biosynthesis
Chemical
Reg. No./Substance:
0/Aldehydes; 29343-52-0/4-hydroxy-2-nonenal; 70-18-8/Glutathione; EC 2.7.7.49/Telomerase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Close correlation between anxiety, depression, and asthma control.
Next Document:  Beyond blood lipids: phytosterols, statins and omega-3 polyunsaturated fatty acid therapy for hyperl...